
GLP-1 stands for glucagon-like peptide-1. Drugs that activate its receptor are called GLP-1 receptor agonists (GLP-1RAs). Medications targeting this pathway are approved for indications including type 2 diabetes and obesity. In the United States, tirzepatide, marketed as Zepbound, is also ...
Continue Reading →NOV



